Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02452671 · ClinicalTrials.gov registry record
Observational Plan to Obtain Clinical Experience and Follow up Data on the Use of the ProxiFuse Hammer Toe Device
A clinical trial, sponsored by Cartiva.
- Terminated
- Registry status
- 15
- Enrollment target
NCT02452671 is a clinical trial that was terminated before completion, run by Cartiva. The registered enrollment target is 15 participants.
The verdict
NCT02452671 was terminated before completion, sponsored by Cartiva.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This is a multi-center, non-randomized, observational study to further evaluate the effectiveness and safety of the Proxifuse Hammer Toe Device when utilized for bone fixation. Approximately 4 US sites will participate. The primary endpoint will evaluate the 6 month post surgery change from baseline in the PROMIS Pain Interference computerized adaptive test (CAT) score.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02452671
The ClinicalTrials.gov registry entry for NCT02452671 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cartiva, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02452671 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02452671 about?
NCT02452671 is a clinical study titled "Observational Plan to Obtain Clinical Experience and Follow up Data on the Use of the ProxiFuse Hammer Toe Device". This is a multi-center, non-randomized, observational study to further evaluate the effectiveness and safety of the Proxifuse Hammer Toe Device when utilized for bone fixation. Approximately 4 US sites will participate. The primary endpoint will evaluate the 6 month post surgery change from baseline...
What is the current status of trial NCT02452671?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2015-06. Estimated completion is 2017-02.
Who is sponsoring clinical trial NCT02452671?
This trial is sponsored by Cartiva, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.